Impact of Weight Loss Drugs on Pregnancies: Risks and Recommendations

The use of weight loss drugs has been a popular method for many individuals looking to shed excess pounds. However, British scientists have issued a warning about the potential risks associated with these drugs, particularly when it comes to pregnancy.

According to experts, weight loss drugs containing ingredients like semaglutide, found in drugs such as Wegovy and Ozempic, can be harmful during pregnancy. Research conducted on pregnant animals has shown that these drugs can be toxic and lead to abnormalities and even miscarriage.

While weight loss drugs are known to boost fertility by reducing excess fat that can interfere with hormone levels, the effects of these drugs on pregnant women and their babies are still unknown. Semaglutide has never been tested on pregnant women, raising concerns about its potential impact on both mother and child.

Doctors in the US typically prescribe these drugs to treat conditions like polycystic ovary syndrome (PCOS), a common cause of infertility in women. However, the use of weight loss drugs during pregnancy is strongly discouraged due to the potential risks involved.

It is important for women to avoid using weight loss drugs within two months of trying to conceive and to consult with their healthcare provider before using these medications. While these drugs may help with weight loss and fertility in some cases, the safety of their use during pregnancy remains a concern.

Researchers emphasize the need for regulatory approvals and further studies on the effects of weight loss drugs on pregnant women before considering them as a treatment for infertility. In the meantime, it is crucial for women to prioritize their health and well-being, especially when it comes to pregnancy and fertility.